Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com.
Ajinomoto provides animal cell culture media for biopharmaceuticals under “CELLiST ™” brand globally.
Besides off-the-shelf products, contract manufacturing of customer’s in-house formulation, optimization of customer’s process or media and various services are available.
We have established a factory company Ajinomoto Genexine Co., Ltd. in Incheon in 2012 and holds abundant experience of commercial supply for biopharmaceutical production.
“Your success is our success” – supporting your project with close communication and reliable scientific background.
For more than 75 years, Kerry has provided integrated solutions for the world’s leading biotechnology customers. We provide cell nutrition supplements including protein hydrolysates, yeast extracts, recombinant proteins, cell line tailored supplement systems and chemically defined medium. We deliver innovative solutions to assist customers maximize yields and cell performance in biotechnological production systems.